| scholarly article | Q13442814 |
| P50 | author | Andrew John Lees | Q4757729 |
| P2093 | author name string | T Revesz | |
| M J White | |||
| L Mancini | |||
| T A Yousry | |||
| C Strand | |||
| M A Miranda | |||
| P-W So | |||
| J S Thornton | |||
| J Holton | |||
| H G Parkes | |||
| L A Massey | |||
| O Al-Helli | |||
| P2860 | cites work | High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease | Q22065275 |
| Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson??s disease | Q22065953 | ||
| Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. | Q53226026 | ||
| Direct visualization of Parkinson's disease by in vivo human brain imaging using 7.0T magnetic resonance imaging. | Q53428460 | ||
| Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy | Q57384519 | ||
| Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans | Q59544688 | ||
| Calbindin D28k-containing neurons are restricted to the medial substantia nigra in humans | Q59544703 | ||
| Quantitative analysis of the variability of substantia nigra pigmented cell clusters in the human | Q59544709 | ||
| Progressive supranuclear palsy: MRI and pathological findings. | Q67401772 | ||
| The anatomy and pigmentation of the human substantia nigra in relation to selective neuronal vulnerability | Q68485947 | ||
| Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes | Q69793199 | ||
| Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization | Q69802862 | ||
| Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease | Q72319648 | ||
| Midbrain iron content in early Parkinson disease: a potential biomarker of disease status | Q80437646 | ||
| The 'swallow tail' appearance of the healthy nigrosome - a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T | Q28660352 | ||
| Ageing and Parkinson's disease: substantia nigra regional selectivity | Q29615835 | ||
| User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability | Q29615939 | ||
| MR imaging in progressive supranuclear palsy and Shy-Drager syndrome | Q31117527 | ||
| Anatomy of the substantia nigra and subthalamic nucleus on MR imaging | Q33517187 | ||
| Effects of aging on the ventral and dorsal substantia nigra using diffusion tensor imaging | Q34014486 | ||
| Imaging of the aging brain. Part II. Pathologic conditions | Q34171841 | ||
| Using high-resolution MR imaging at 7T to evaluate the anatomy of the midbrain dopaminergic system | Q34792120 | ||
| An assessment of current brain targets for deep brain stimulation surgery with susceptibility-weighted imaging at 7 tesla | Q35072905 | ||
| Case control study of diffusion tensor imaging in Parkinson's disease. | Q36172532 | ||
| Imaging of the aging brain. Part I. Normal findings | Q36444753 | ||
| Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders | Q36727210 | ||
| Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease | Q36947501 | ||
| Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI. | Q37178767 | ||
| Improved segmentation of deep brain grey matter structures using magnetization transfer (MT) parameter maps | Q37222250 | ||
| Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis. | Q37313955 | ||
| Substance P in the human brain | Q38492563 | ||
| MRI characteristics of the substantia nigra in Parkinson's disease: a combined quantitative T1 and DTI study | Q39979236 | ||
| Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata | Q42437565 | ||
| Substantia nigra in progressive supranuclear palsy, corticobasal degeneration, and parkinsonism-dementia complex of Guam: specific pathological features. | Q42502877 | ||
| The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings. | Q44213359 | ||
| Reduction of the substantia nigra width and motor decline in aging and Parkinson's disease | Q44491341 | ||
| MR imaging of Parkinson disease with spin-echo and gradient-echo sequences | Q45809141 | ||
| High resolution MR anatomy of the subthalamic nucleus: imaging at 9.4 T with histological validation. | Q47578613 | ||
| Evaluation of the substantia nigra in patients with Parkinsonian syndrome accomplished using multishot diffusion-weighted MR imaging. | Q48097427 | ||
| MRI correlates of pathology in parkinsonism: segmented inversion recovery ratio imaging (SIRRIM). | Q48131860 | ||
| The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease | Q48147372 | ||
| The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry | Q48147383 | ||
| Study of movement disorders and brain iron by MR. | Q48229024 | ||
| Magnetic resonance imaging of the midbrain in Parkinson's disease | Q48267036 | ||
| Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism | Q48279155 | ||
| Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease | Q48478915 | ||
| Ageing of substantia nigra in humans: cell loss may be compensated by hypertrophy | Q48513302 | ||
| Inversion recovery MRI in idiopathic Parkinson disease is a very sensitive tool to assess neurodegeneration in the substantia nigra: preliminary investigation | Q48552233 | ||
| Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts | Q48616749 | ||
| Seven-Tesla magnetic resonance images of the substantia nigra in Parkinson disease | Q48639223 | ||
| The shrinkage of the human brain stem during formalin fixation and embedding in paraffin | Q48657041 | ||
| Striatonigral degeneration. A clinicopathological study | Q48842299 | ||
| Olivopontocerebellar atrophy: MR diagnosis and relationship to multisystem atrophy | Q49077150 | ||
| Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. | Q50562845 | ||
| Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla. | Q52371728 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P921 | main subject | substantia nigra | Q753278 |
| P304 | page(s) | 154-163 | |
| P577 | publication date | 2016-11-17 | |
| P1433 | published in | NeuroImage: Clinical | Q22907265 |
| P1476 | title | 9.4 T MR microscopy of the substantia nigra with pathological validation in controls and disease | |
| P478 | volume | 13 |
| Q64252277 | Brain Iron Accumulation in Atypical Parkinsonian Syndromes: MRI Evidences for Distinctive Patterns |
| Q50043640 | Diagnosis of Early-Stage Idiopathic Parkinson's Disease Using High-Resolution Quantitative Susceptibility Mapping Combined with Histogram Analysis in the Substantia Nigra at 3 T. |
| Q47416232 | Differential involvement of nigral subregions in idiopathic parkinson's disease |
| Q90089288 | Do the Magic Angle Effects or Susceptibility Effects Affect the Visualization of Nigrosome 1? |
| Q46753514 | Head to head comparison of [(18)F] AV-1451 and [(18)F] THK5351 for tau imaging in Alzheimer's disease and frontotemporal dementia. |
| Q46311520 | Human brain imaging of nicotinic acetylcholine α4β2* receptors using [18 F]Nifene: Selectivity, functional activity, toxicity, aging effects, gender effects, and extrathalamic pathways. |
| Q92209298 | Imaging the Nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: An application to Parkinson's disease |
| Q64787913 | Iron-related nigral degeneration influences functional topology mediated by striatal dysfunction in Parkinson's disease |
| Q92870955 | Mapping internal brainstem structures using MP2RAGE derived T1 weighted and T1 relaxation images at 3 and 7 T |
| Q92104991 | Matching ex vivo MRI With Iron Histology: Pearls and Pitfalls |
| Q99731938 | Multimodal assessment of nigrosomal degeneration in Parkinson's disease |
| Q55312441 | Parkinson's disease related signal change in the nigrosomes 1-5 and the substantia nigra using T2* weighted 7T MRI. |
| Q91797487 | Post-Mortem MRI and Histopathology in Neurologic Disease: A Translational Approach |
| Q52573281 | Present and Future of Ultra-High Field MRI in Neurodegenerative Disorders. |
| Q92403055 | Radiomic Features of the Nigrosome-1 Region of the Substantia Nigra: Using Quantitative Susceptibility Mapping to Assist the Diagnosis of Idiopathic Parkinson's Disease |
| Q64759313 | Structural Imaging in Parkinson's Disease: New Developments |
Search more.